142 related articles for article (PubMed ID: 15027876)
1. Design and synthesis of 3'- and 5'-O-(3-benzenesulfonylfuroxan-4-yl)-2'-deoxyuridines: biological evaluation as hybrid nitric oxide donor-nucleoside anticancer agents.
Moharram S; Zhou A; Wiebe LI; Knaus EE
J Med Chem; 2004 Mar; 47(7):1840-6. PubMed ID: 15027876
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of 3'- and 5'-nitrooxy pyrimidine nucleoside nitrate esters: "nitric oxide donor" agents for evaluation as anticancer and antiviral agents.
Naimi E; Zhou A; Khalili P; Wiebe LI; Balzarini J; De Clercq E; Knaus EE
J Med Chem; 2003 Mar; 46(6):995-1004. PubMed ID: 12620076
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of 1-(2-deoxy-beta-D-ribofuranosyl)-2,4-difluoro-5-substituted-benzenes: "thymine replacement" analogs of thymidine for evaluation as anticancer and antiviral agents.
Wang ZX; Duan W; Wiebe LI; Balzarini J; De Clercq E; Knaus EE
Nucleosides Nucleotides Nucleic Acids; 2001; 20(1-2):41-58. PubMed ID: 11303562
[TBL] [Abstract][Full Text] [Related]
4. 5-alkynyl analogs of arabinouridine and 2'-deoxyuridine: cytostatic activity against herpes simplex virus and varicella-zoster thymidine kinase gene-transfected cells.
Cristofoli WA; Wiebe LI; De Clercq E; Andrei G; Snoeck R; Balzarini J; Knaus EE
J Med Chem; 2007 Jun; 50(12):2851-7. PubMed ID: 17518459
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and biological evaluation of 3,4-diphenyl-1,2,5-oxadiazole-2-oxides and 3,4-diphenyl-1,2,5-oxadiazoles as potential hybrid COX-2 inhibitor/nitric oxide donor agents.
Velázquez C; Rao PN; McDonald R; Knaus EE
Bioorg Med Chem; 2005 Apr; 13(8):2749-57. PubMed ID: 15781386
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of unnatural 7-substituted-1-(2-deoxy-beta-D-ribofuranosyl)isocarbostyrils: "thymine replacement" analogs of deoxythymidine for evaluation as antiviral and anticancer agents.
Naimi E; Duan W; Wiebe LI; Knaus EE
Nucleosides Nucleotides Nucleic Acids; 2001 Aug; 20(8):1533-53. PubMed ID: 11554544
[TBL] [Abstract][Full Text] [Related]
7. Novel nitric oxide-releasing derivatives of farnesylthiosalicylic acid: synthesis and evaluation of antihepatocellular carcinoma activity.
Ling Y; Ye X; Zhang Z; Zhang Y; Lai Y; Ji H; Peng S; Tian J
J Med Chem; 2011 May; 54(9):3251-9. PubMed ID: 21504204
[TBL] [Abstract][Full Text] [Related]
8. Syntheses, calcium channel agonist-antagonist modulation activities, and nitric oxide release studies of nitrooxyalkyl 1,4-dihydro-2,6-dimethyl-3-nitro-4-(2,1,3-benzoxadiazol-4-yl)pyridine-5-carboxylate racemates, enantiomers, and diastereomers.
Shan R; Velazquez C; Knaus EE
J Med Chem; 2004 Jan; 47(1):254-61. PubMed ID: 14695839
[TBL] [Abstract][Full Text] [Related]
9. A human osteosarcoma cell line expressing herpes simplex type-1 thymidine kinase: studies with radiolabeled (E)-5-(2-iodovinyl)-2'-fluoro-2'-deoxyuridine.
Morin KW; Duan W; Knaus EE; McEwan AJ; Wiebe LI
Nucl Med Biol; 2005 Jul; 32(5):459-64. PubMed ID: 15982576
[TBL] [Abstract][Full Text] [Related]
10. Radiosynthesis, in vitro cellular uptake and in vivo biodistribution of 3'-O-(3-benzenesulfonylfuroxan-4-yl)-5-[125I]iodo-2'-deoxyuridine, a nucleoside-based nitric oxide donor.
Moharram S; Zhou A; Kumar P; Knaus EE; Wiebe LI
Nucl Med Biol; 2005 Aug; 32(6):641-5. PubMed ID: 16026711
[TBL] [Abstract][Full Text] [Related]
11. Novel nonsteroidal antiinflammatory drugs possessing a nitric oxide donor diazen-1-ium-1,2-diolate moiety: design, synthesis, biological evaluation, and nitric oxide release studies.
Velázquez C; Praveen Rao PN; Knaus EE
J Med Chem; 2005 Jun; 48(12):4061-7. PubMed ID: 15943479
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and anticancer activities of novel 3,5-disubstituted-1,2,4-oxadiazoles.
Kumar D; Patel G; Johnson EO; Shah K
Bioorg Med Chem Lett; 2009 May; 19(10):2739-41. PubMed ID: 19376704
[TBL] [Abstract][Full Text] [Related]
13. Celecoxib analogs possessing a N-(4-nitrooxybutyl)piperidin-4-yl or N-(4-nitrooxybutyl)-1,2,3,6-tetrahydropyridin-4-yl nitric oxide donor moiety: synthesis, biological evaluation and nitric oxide release studies.
Chowdhury MA; Abdellatif KR; Dong Y; Yu G; Huang Z; Rahman M; Das D; Velázquez CA; Suresh MR; Knaus EE
Bioorg Med Chem Lett; 2010 Feb; 20(4):1324-9. PubMed ID: 20097072
[TBL] [Abstract][Full Text] [Related]
14. Antitumor platinum(II) complexes containing platinum-based moieties of present platinum drugs and furoxan groups as nitric oxide donors: synthesis, DNA interaction, and cytotoxicity.
Zhao J; Gou S; Sun Y; Fang L; Wang Z
Inorg Chem; 2012 Oct; 51(19):10317-24. PubMed ID: 22957695
[TBL] [Abstract][Full Text] [Related]
15. An efficient synthesis and biological study of novel indolyl-1,3,4-oxadiazoles as potent anticancer agents.
Kumar D; Sundaree S; Johnson EO; Shah K
Bioorg Med Chem Lett; 2009 Aug; 19(15):4492-4. PubMed ID: 19559607
[TBL] [Abstract][Full Text] [Related]
16. Chemical insights in the concept of hybrid drugs: the antitumor effect of nitric oxide-donating aspirin involves a quinone methide but not nitric oxide nor aspirin.
Hulsman N; Medema JP; Bos C; Jongejan A; Leurs R; Smit MJ; de Esch IJ; Richel D; Wijtmans M
J Med Chem; 2007 May; 50(10):2424-31. PubMed ID: 17441704
[TBL] [Abstract][Full Text] [Related]
17. Licofelone-nitric oxide donors as anticancer agents.
Liu W; Zhou J; Liu Y; Liu H; Bensdorf K; Guo C; Gust R
Arch Pharm (Weinheim); 2011 Aug; 344(8):487-93. PubMed ID: 21681808
[TBL] [Abstract][Full Text] [Related]
18. Dinitroglyceryl and diazen-1-ium-1,2-diolated nitric oxide donor ester prodrugs of aspirin, indomethacin and ibuprofen: synthesis, biological evaluation and nitric oxide release studies.
Abdellatif KR; Chowdhury MA; Dong Y; Das D; Yu G; Velázquez CA; Suresh MR; Knaus EE
Bioorg Med Chem Lett; 2009 Jun; 19(11):3014-8. PubMed ID: 19419861
[TBL] [Abstract][Full Text] [Related]
19. Diazen-1-ium-1,2-diolated nitric oxide donor ester prodrugs of 1-(4-methanesulfonylphenyl)-5-aryl-1H-pyrazol-3-carboxylic acids: synthesis, nitric oxide release studies and anti-inflammatory activities.
Abdellatif KR; Chowdhury MA; Dong Y; Knaus EE
Bioorg Med Chem; 2008 Jul; 16(13):6528-34. PubMed ID: 18513975
[TBL] [Abstract][Full Text] [Related]
20. Diazen-1-ium-1,2-diolated nitric oxide donor ester prodrugs of 5-(4-carboxymethylphenyl)-1-(4-methanesulfonylphenyl)-3-trifluoromethyl-1H-pyrazole and its aminosulfonyl analog: Synthesis, biological evaluation and nitric oxide release studies.
Abdellatif KR; Chowdhury MA; Dong Y; Das D; Yu G; Velázquez C; Suresh MR; Knaus EE
Bioorg Med Chem; 2009 Jul; 17(14):5182-8. PubMed ID: 19500994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
